Clinical trial
NMRC-M3V-Ad-PfCA Vaccine - Clinical Trial 1
NCT00392015 · U.S. Army Medical Research and Development Command, U.S. Fed · Completed
Key facts
| NCT number | NCT00392015 |
|---|---|
| Title | NMRC-M3V-Ad-PfCA Vaccine - Clinical Trial 1 |
| Official title | A Two Part Clinical Trial Assessing the Safety, Tolerability, Immunogenicity and Protective Efficacy of NMRC-M3V-Ad-PfCA, a Multivalent, Adenovirus-Vectored Plasmodium Falciparum Malaria Vaccine, in Healthy, Malaria-Naïve Adults |
| Lead sponsor | U.S. Army Medical Research and Development Command, U.S. Fed |
| Collaborators | United States Agency for International Development (USAID) U.S. Fed Congressionally Directed Medical Research Programs Military Infectious Diseases Research Program (MIDRP) Naval Medical Research… |
| Status | Completed |
| Phase | Phase 1/Phase 2 |
| Study type | Interventional |
| Conditions | Plasmodium Falciparum |
| Intervention type | Biological |
| Interventions | NMRC-M3V-Ad-PfCA, NMRC-MV-Ad-PfC |
| Enrollment | 59 |
| Start date | Oct 12, 2006 |
| Primary completion | Jun 2, 2016 |
| Completion | Sep 25, 2017 |
| First posted | Oct 25, 2006 |
| Last update posted | May 21, 2021 |
| Countries | United States |
At a glance
- 1–9 Study sites
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: